跳至內容

BRL-37344

維基百科,自由的百科全書
BRL-37344
臨床資料
商品名英語Drug nomenclatureBRL-37344
法律規範狀態
法律規範
  • Investigational New Drug
識別資訊
  • 2-{4-[(2R)-2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl]phenoxy}acetic acid
CAS號114333-71-0
PubChem CID
CompTox Dashboard英語CompTox Chemicals Dashboard (EPA)
化學資訊
化學式C19H22ClNO4
摩爾質量363.8
3D模型(JSmol英語JSmol
  • C[C@H](CC1=CC=C(C=C1)OCC(=O)O)NC[C@@H](C2=CC(=CC=C2)Cl)O
  • InChI=1S/C19H22ClNO4/c1-13(21-11-18(22)15-3-2-4-16(20)10-15)9-14-5-7-17(8-6-14)25-12-19(23)24/h2-8,10,13,18,21-22H,9,11-12H2,1H3,(H,23,24)/t13-,18+/m1/s1
  • Key:ZGGNJJJYUVRADP-ACJLOTCBSA-N

BRL-37344是一種藥物,分子式C19H22ClNO4,為β-3腎上腺素英語Beta-3 adrenergic receptor受體選擇性激動劑[1]已針對各種生物醫學的應用開展了相關研究,但尚未提供臨床使用。[2][3][4][5][6][7]

參考文獻

[編輯]
  1. ^ Bond RA, Clarke DE. Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes. British Journal of Pharmacology. November 1988, 95 (3): 723–34. PMC 1854239可免費查閱. PMID 2905184. doi:10.1111/j.1476-5381.1988.tb11698.x. 
  2. ^ Napp A, Brixius K, Pott C, Ziskoven C, Boelck B, Mehlhorn U, et al. Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium. Journal of Cardiac Failure. February 2009, 15 (1): 57–67. PMID 19181295. doi:10.1016/j.cardfail.2008.08.006. 
  3. ^ Afeli SA, Rovner ES, Petkov GV. BRL37344, a β3-adrenergic receptor agonist, decreases nerve-evoked contractions in human detrusor smooth muscle isolated strips: role of BK channels. Urology. September 2013, 82 (3): 744.e1–7. PMC 3758792可免費查閱. PMID 23890664. doi:10.1016/j.urology.2013.05.027. 
  4. ^ Maryanovich M, Zahalka AH, Pierce H, Pinho S, Nakahara F, Asada N, et al. Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche. Nature Medicine. June 2018, 24 (6): 782–791. PMC 6095812可免費查閱. PMID 29736022. doi:10.1038/s41591-018-0030-x. 
  5. ^ Xu Z, Wu J, Xin J, Feng Y, Hu G, Shen J, et al. β3-adrenergic receptor activation induces TGFβ1 expression in cardiomyocytes via the PKG/JNK/c-Jun pathway. Biochemical and Biophysical Research Communications. September 2018, 503 (1): 146–151. PMID 29859189. doi:10.1016/j.bbrc.2018.05.200. 
  6. ^ Grzelka K, Gawlak M, Czarzasta K, Szulczyk P. β3-adrenergic receptor stimulation on the resting holding current of medial prefrontal cortex pyramidal neurons in young rats. Neuroscience Letters. April 2019, 698: 192–197. PMID 30641111. doi:10.1016/j.neulet.2019.01.022. 
  7. ^ Fellous TG, Redpath AN, Fleischer MM et al. Pharmacological tools to mobilise mesenchymal stromal cells into the blood promote bone formation after surgery. npj Regen Med 2020; 5: 3. doi:10.1038/s41536-020-0088-1